Viokase: profile and news

Axcan announces record revenue of $72.8 million for the second ...  May 4, 2006
ULTRASE-VIOKASE In April 2004, the FDA formally notified manufacturers of pancreatic insufficiency products that these drugs must receive approval before April ... - Canada NewsWire (press release),

Axcan announces record revenue of $72.8 million for the second ...  May 4, 2006
...products. Axcan has completed a Phase III study of VIOKASE that will serve as the basis of the New Drug Application. Additional ... - Yahoo! News (press release)